Beijing Chaoyang Hospital is a hospital in Chaoyang District, Beijing. It is subordinate to the Beijing Municipal Healthcare Bureau. It is the third clinical hospital of the medical school of Capital Medical University.

During the past decade, Beijing ChaoYang Hospital conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 8 clinical trials were completed, i.e. on average, 10.3% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 3 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing ChaoYang Hospital" #1 sponsor was "Beijing Chao Yang Hospital" with 16 trials, followed by "Capital Medical University" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Harbin Medical University" with 3 trials sponsored and "McMaster University" with 3 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing ChaoYang Hospital" #1 collaborator was "Beijing Chao Yang Hospital" with 7 trials as a collaborator, "Peking Union Medical College Hospital" with 6 trials as a collaborator, "Chinese PLA General Hospital" with 3 trials as a collaborator, "First Affiliated Hospital of Wenzhou Medical University" with 3 trials as a collaborator and "First Affiliated Hospital of Zhejiang University" with 3 trials as a collaborator. Other collaborators include 216 different institutions and companies that were collaborators in the rest 151 trials.

According to Clinical.Site data, the most researched conditions in "Beijing ChaoYang Hospital" are "Multiple Myeloma" (9 trials), "Coronary Artery Disease" (4 trials), "Acute Myocardial Infarction" (2 trials), "COPD" (2 trials) and "Chronic Thromboembolic Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "Beijing ChaoYang Hospital" in a lesser frequency.

Most popular intervention types in "Beijing ChaoYang Hospital" are "Drug" (54 trials), "Procedure" (14 trials), "Device" (13 trials), "Behavioral" (5 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Dexamethasone" (5 trials), "Bortezomib" (4 trials), "Daratumumab" (4 trials) and "Carfilzomib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Beijing ChaoYang Hospital" are 98 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 48 active trials in "Beijing ChaoYang Hospital". 3 are not yet recruiting, 31 are recruiting, 11 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 23 completed trials in Beijing ChaoYang Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing ChaoYang Hospital, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 37 trials that are defined as “Not Applicable".